GHRL and Alzheimer disease: Although further evidence and investigation are required, a previous study by Yoshino et al. (2018) showed increased levels of serum acyl-ghrelin in AD subjects compared to control subjects that might be a result of changes of the ghrelin pathway in brain (Yoshino et al., 2018).